Generated by AI
Pluri Inc. is a biotechnology company focused on the research, development, manufacturing, and commercialization of cell-based products and related technologies. The company uses its proprietary three-dimensional cell expansion platform to support scalable cell production for applications across regenerative medicine, immunotherapy, food technology, and agricultural technology. Its current business areas include cell therapeutics, cultivated food solutions, and contract development and manufacturing services, reflecting a diversified platform built around advanced cell engineering. Pluri Inc. serves markets that rely on biological innovation to address medical, industrial, and sustainability challenges, positioning itself as a provider of cell-based solutions for both therapeutic and non-therapeutic uses. Headquartered in Haifa, Israel, Pluri Inc. operates as a clinical-stage biotechnology company with a focus on translating cell technology into practical commercial products and services.
WebsiteMATAM Advanced Technology Park
Haifa, 3508409
Israel
The latest articles about PLUR.
Pluri is translating more than two decades of cell-technology, manufacturing and clinical experience into a focused commercial strategyRegenerative medicine and the U.S. market are central to this next phase, supported by ZEO, CellaV and PluriCDMOClinical progress, strategic partnerships and greater financial alignment provide multiple avenues to unlock value across Pluri’s asset base HAIFA, Israel, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq and TASE: PLUR) (“Pluri” or the “Company”) t
Summary of Oct 27's posts. Generated by AI.
Summary of Jan 10's posts. Generated by AI.
English-language call at 8:30 a.m. Eastern Time and Hebrew-language call at 11:00 a.m. Israel Time on Thursday, October 29, 2026HAIFA, Israel, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq and TASE: PLUR) (“Pluri” or the “Company”), a biotechnology company advancing cell-based solutions for health and longevity, will host an online investor conference via Zoom this coming Thursday, October 29, 2026, featuring Mr. Yaky Yanay, CEO and President of Pluri and Mr. Alejandro Weinstein, Chairman
No summary yet.
Summary of Dec 16's posts. Generated by AI.
Investors talking about PLUR also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.